• Unique approach to studying biorelevant drug dissolution
  • One API – One method
  • Proven to achieve Level A IVIVC
  • Level A IVIVC achieved across all four BCS classes

  • Use one method throughout product development

  • Compatible with a large range of dosage forms

  • Use of different biorelevant media to simulate a range of physiologies

  • High sensitivity allows for the detection of drug loading variability between batches

  • Extremely reproducible data provide a high level of confidence in results

  • No need for mathematical IVIVC models because concentration versus time profiles are created from raw data

  • Potential to reduce speed to market by reducing clinical trials

  • Evaluation of FloVitro™ has been funded by the US FDA

Learn more ...

LibrarySupportContact Us